Development of inhibitors in women with mild haemophilia A and concurrent treatment with immune tolerance therapy and emicizumab

Haemophilia. 2023 Jul;29(4):1167-1169. doi: 10.1111/hae.14821. Epub 2023 Jul 1.

Authors

May Anne Cheong¹, Jun Yang Ang¹, Shim Yen Yeam¹, Heng Joo Ng¹, Sim Leng Tien¹

Affiliation

¹ Department of Haematology, Singapore General Hospital, Singapore, Singapore.

PMID: 37392447
DOI: 10.1111/hae.14821

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Bispecific* / pharmacology
Antibodies, Monoclonal, Humanized / pharmacology
Female
Hemophilia A* / drug therapy
Humans
Immune Tolerance

Substances

Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
emicizumab